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INTRODUCTION
Cytochrome P450s (CYPs, P450s) comprise the superfamily of heme-containing oxidoreductase enzymes found in various organisms including animals, plants, fungi and bacteria (Ortiz de Montellano, 2005) . In humans, CYPs are responsible for the metabolism of various endogenous and exogenous chemicals including drugs (Guengerich, 2005) . Among 57 human CYPs, CYP4A11 is a major fatty acid hydroxylase found in human liver (Guengerich, 2005) . It catalyzes the hydroxylation of saturated and unsaturated fatty acids mainly at the terminal carbon position and therefore converts lauric acid to 12-hydroxylauric acid (Okita and Okita, 2001; He et al., 2005) . This terminal hydroxylation of fatty acids is considered to maintain the balance of lipids in human liver (Adas et al., 1999) . It is also involved in the terminal oxidation reaction of arachidonic acid to produce 20-hydroxyeicosatetraenoic acid (20-HETE), which known as a regulator of blood pressure (Gainer et al., 2005) . The production of 20-HETE is relatively unique among the human P450s and therefore, the regulation of CYP4A11 activity can suggest a new therapeutic approach to control hypertension.
Random mutagenesis and subsequent screening (socalled directed evolution) is an effective tool to engineer enzymes or to investigate structure-function relationships of proteins. CYP enzymes have been gaining particular attention for their applications in biotransformation and in the study of structure-function relationships (Kim et al., 2005) . In previous studies, the formations of dye products and fl uorescent metabolite were used for effi cient screening of interesting clones from CYP2A6 random mutant libraries (Nakamura et al., 2001; Kim et al., 2005) . Also, CYP-mediated mutagenic bioactivation was applied to select CYP1A2 mutants with enhanced catalytic activity (Kim and Guengerich, 2004b) . Three consecutive
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Biomol Ther 21(6), 487-492 (2013) http://dx.doi.org/10.4062/biomolther.2013.086 rounds of random mutagenesis and screening yielded a highly improved CYP1A2 mutant with a >10-fold increase in the bioactivation of aromatic amine based on the genotoxicity assay and a 12-fold enhanced catalytic effi ciency in steady-state analysis (Kim and Guengerich, 2004b) .
Recently, many luminogenic CYP assays were introduced using various prosubstrates for the light-generating reaction of fi refl y luciferase. The general principle is that CYPs convert prosubstrates to an active luciferin, which produces light in the second reaction with a luciferase (Fig. 1) (Cali et al., 2006) . The amount of light generated is proportional to the amount of luciferin produced by the CYP enzyme and its activity. It was shown that CYP4A11 selectively converts a luciferin derivative, 2-(6-methoxyquinolin-2-yl)-4,5-dihydrothiazole-4-carboxylic acid (Luciferin-4A), to quinolylluciferin, an active alternative to native beetle luciferin (Branchini et al., 1989) .
In this study, we applied a luminogenic CYP substrate and identifi ed human CYP4A11 mutants with enhanced catalytic activity using random mutagenesis and high-throughput screening. The selected mutants were evaluated for their fatty acid hydroxylation and luminescence production activities.
MATERIALS AND METHODS

Chemicals
, and NADPH were purchased from SigmaAldrich (St. Louis, MO, USA). Luciferin-4A (2-(6-methoxyquinolin-2yl)-4,5-dihydrothiazole-4-carboxylic acid), and luciferin detection reagent (LDR) were purchased from Promega (Madison, WI, USA). Ni 2+ -nitrilotriacetate (NTA) agarose was purchased from Qiagen, (Valencia, CA, USA). Other chemicals were of the highest commercially available grade. Escherichia coli DH10b and DH5α cells were purchased from Invitrogen (Life Technologies, Grand Island, NY, USA). Rat NADPH-P450 reductase (NPR) was heterolously expressed in E. coli (TOPP3 strain) and purifi ed as described elsewhere (Han et al., 2009; Lee et al., 2012) 
Construction of CYP4A11 random mutant library plasmids
The open reading frame of human CYP4A11 was randomly mutated using the low-fi delity polymerase PCR method as previously described (Kim and Guengerich, 2004b) . Random mutagenesis PCR reactions were conducted using GeneMorph II Random Mutagenesis Kit (Stratagene, La Jolla, CA, USA) with the following primers: 5'-AACCACATATGGCTCT-GTTA-3' (N-terminal primer) and 5'-GGTAGTCTAGATTAATG-GTG-3' (C-terminal primer). The amplifi ed PCR library fragment was purifi ed and cloned into the pCW4A11 bicistronic vector , which also expresses NADPH-P450 reductase. The ligation mixture was transformed into E. coli DH10b ultracompetent cells, and then the library plasmid DNA was purifi ed.
Luminescence high-throughput screening
Constructed library plasmids of CYP4A11 were transformed into E. coli DH5α, and individual colonies were picked up and transferred to single wells of 96-microtiter plates fi lled with 200 μl of Terrifi c Broth (TB) expression media including ampicillin and supplements (0.5 mM 5-aminolevulinic acid, 1.0 mM isopropyl β-d-thiogalactoside, 1.0 mM thiamine, and trace elements). For each generation of library screening, ~1.5×10 3 colonies were picked and, the 96-well plates were incubated at 28 o C for 48 hr. For the measurement of luminescent activity of mutants, M9 medium including the Luciferin-4A substrate (and glucose) was added after TB medium was removed with centrifugation. After 20 min of incubation at 37 o C, the reaction was stopped with the addition of Luciferin Detection Reagent (including luciferase, CYP-Glo TM Screening System) and further incubated at room temperature for 20 min to stabilize the luminescent signal. Luminescence was detected using a 96-microtiter luminometer (Veritas, Promega).
Protein expression and purifi cation
Expression and purifi cation of CYP4A11 mutants were carried out as previously described with some modifi cations (Kim et al., 2005) . The E. coli DH5α strains transformed with pCW vectors were inoculated into LB medium containing 50 μg/ml ampicillin and incubated overnight at 37 o C. LB cultures were then seeded into 500 ml of Terrifi c broth (TB) expression medium containing 50 μg/ml ampicillin. The expression cultures were grown at 37 o C with shaking at 250 rpm. When the OD 600 of the cultures reached 0.5, supplements were added, and the expression cultures were further grown at 28 o C with shaking at 200 rpm for 48 hr. Bacterial inner membrane fractions containing CYP4A11 wild type and mutants were isolated and prepared from TB expression cultures, by the method described previously (Han et al., 2009) . The prepared membrane fractions were solubilized overnight at 4 o C in 100 mM potassium phosphate buffer (pH 7.4) including 20% glycerol, 0.1 mM EDTA, 10 mM β-mercaptoethanol, and 1.5% CHAPS (w/v). Purifi cation of enzymes using a Ni 2+ -nitrilotriacetate column eluted with 300 mM imidazole, was also performed using a previously described method (Yun et al., 2000) .
Fig. 1. Generation of luminescence by CYP4A11 and Luciferin
Detection Reagent (LDR). LDR includes luciferase enzyme to produce the luminescent light using luciferin.
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Analysis of lauric acid hydroxylation using GC-mass spectrometry
Lauric acid hydroxylation activity was determined by GCmass spectrometry as described (Han et al., 2009) . The reaction mixtures consisted of 0.1 mM purifi ed P450 protein in 100 mM potassium phosphate buffer (pH 7.4) including 0.2 mM rat NADPH-P450 reductase, DLPC (0.1 mg/ml), 0.1 mM cytochrome b 5 and 500 μM of dithiothreitol (DTT), and varying concentrations of lauric acid in a total volume of 0.5 ml. The reaction was initiated by adding an NADPH-generating system [0.5 mM NADP + , 10 mM glucose 6-phosphate, and 1.0 IU glucose 6-phosphate dehydrogenase mL
-1 ] at 37 o C and terminated with addition of 1 ml of CH 2 Cl 2 after 20 min. The CH 2 Cl 2 extract was dried under N 2 and then converted to trimethylsilyl derivatives by incubation with 50 μl of N,O-bis(trimethylsilyl)trifl uoroacetamide at 70°C for 10 min. The derivatized samples were analyzed on the Varian 240 ion-trap gas chromatograph mass spectrometry system.
Substrate binding spectral titration
Purifi ed CYP4A11 mutant enzymes were diluted to 2 μM in 100 mM potassium phosphate buffer (pH 7.4) and then divided between two glass cuvettes. Spectral changes (from 350 to 500 nm) were recorded with subsequent addition of lauric acid in methanol using a CARY 100 spectrophotometer (Varian). Binding affi nities were estimated by fi tting the data of absorbance difference to the quadratic equation using nonlinear regression analysis with Graph-Pad Prism software (GraphPad, San Diego, CA, USA).
RESULTS
Random mutagenesis and selection of CYP4A11 mutants
Random mutant library of CYP4A11 in pCW bicistronic vectors was successfully generated in the error-prone PCR reaction. The constructed mutant library was screened for mutant clones with activity to produce increased luminescence (Fig.  1) . About 1.5×10 3 clones were screened in the 1st generation mutant library, and putative 28 mutants were selected and verifi ed as positive clones with the enhanced activity (Fig. 2) . CP2600 mutant showed highly enhanced activity to produce luminescence among the selected 1st generation mutants. CP2600 mutant had double mutations, A24T and T263A. Interestingly, Ala24 was not the native sequence of CYP4A11 but a part of N-terminal modifi ed sequence to increase the expression level of recombinant proteins (Han et al., 2009) . CP2601 mutant which has only T263A mutation was generated using the site-directed mutation of CP2600 mutant. CP2616 mutant was selected from the consecutive screening analysis of additional random mutant library generated using CP2600 mutant as a PCR template. It contained triple mutations V430E as well as A24T and T263A (which were found in CP2600). Enhanced luminescence was no longer observed in the consecutive screening of random mutant library generated from CP2616 mutant.
Luminescence production by selected CYP4A11 mutants CYP4A11 wild type and the selected mutants were expressed in large scale. The expression levels ranged from 63 to 172 nmol/liter culture (Fig. 3A) . Recombinant proteins of CYP4A11 wild type and three mutants were purifi ed using a Ni 2+ -NTA affi nity chromatography column. The concentrations of all purifi ed proteins were spectroscopically determined to be (Fig. 3B) . These results suggested that three mutations partially affected the structural stability of the recombinant CYP4A11 protein. Demethylation activity of Luciferin-4A [2-(6-methoxyquinolin-2-yl)-4, 5-dihydrothiazole-4-carboxylic acid] was measured using purifi ed CYP4A11 mutant proteins after normalizing the CYP holoenzyme levels (based on CO-binding spectrum). Purifi ed CP2600 and CP-2601 mutants showed >10-fold increases, but CP2616 mutant increased only ~3 fold (Fig. 4) .
Lauric acid hydroxylation activities of selected CYP4A11 mutants
Hydroxylation of lauric acid is a typical enzymatic activity of CYP4A11. In GC-mass spectrometry analysis, CYP4A11 produced mainly ω-hydroxylated lauric acid as a major metabolite at 22 min (Fig. 5) . All three mutants showed signifi cant reductions of lauric acid hydroxylation activities in the steady state kinetic analysis (Fig. 6, Table 1 ). CP2600 mutant showed a 51% decrease in catalytic effi ciency (k cat /K m ) for lauric acid hydroxylation mainly due to an increase in K m value. CP2601 and CP2616 showed much greater reductions in catalytic effi ciency (17-25% of wild-type) due to both decreased k cat and increased K m (Fig. 6, Table 1 ).
Lauric acid binding affi nities of selected CYP4A11 mutants
Binding titration of lauric acid to CYP4A11 wild type and mutants showed a typical type I spectral change (data not shown). Binding affi nities of purifi ed CYP4A11 wild type and mutants for lauric acid were determined (Fig. 7 and Table 2 ). The binding of lauric acid to CYP4A11 wild type yielded a K d value of 5.6 ± 0.6 μM ( Table 2) . CP2600 mutant showed stronger binding with a K d value of 2.5 ± 0.4 μM, but CP2601 and CP2616 mutants exhibited ~2 fold increases in K d values (Table 2) .
DISCUSSION
Although the directed evolution approach is a powerful tool for analyzing the structure and function relationships of proteins, no attempt has been made regarding the study of CYP4A11 due to the lack of its screening method possessing effi ciency and validity. In this study, bioluminescence was used for the high-throughput screening method of CYP4A11 random mutagenesis library. Sobol et al. reported that luciferin-4A is a selective substrate for CYP4A11 among human Table 1. www.biomolther.org CYPs, which showed time dependence and a saturated hyperbolic dose response with a K m value of 80 μM (Sobol et al., 2008) . This approach differs from that previously used for human CYP1A2 and CYP2A6, in which the fl uorescence of specifi c CYP reactions was used for screening (Kim and Guengerich, 2004a; Kim et al., 2005) . The current study identifi ed three CYP4A11 mutants with enhanced luminescence producing activity, CP2600 (A24T/T263A), CP2601 (T263A), and CP2616 (A24T/T263A/V430E), with a ~3-fold increase in whole cells and a >10-fold increase in purifi ed proteins.
Lauric and arachidonic acid are typical substrates for human CYP4A11. Enhancement of catalytic activity in selected mutants was not observed for the hydroxylation of lauric acid. Increased catalytic activity is selective for the luciferin-4A substrate. Luciferin-4A is a quinoline structure and this signifi cant structural difference from lauric acid (or arachidonic acid) may contribute to the changing catalytic activity of selected mutants for lauric acid. This fi nding supports the previous caveat that the effects of any particular mutation are relatively unique to enzyme-substrate complementarity and may diverge with different substrates (Kim and Guengerich, 2004b) . Weaker affi nities of lauric acid to CP2601 and CP2616 mutants may have an effect on the decreased catalytic activity to some extent albeit the stronger binding to CP2600 mutant (Table 2 ).
All of mutations appeared to be located in the regions remote from the proposed substrate binding site based on the sequence alignment of CYP4A11 (data not shown). The T263A mutation, present in all mutants, is located in the Ghelix region. The helix G region contains helical structures rich in hydrophobic residues and therefore it can penetrate into the deep depth of the membrane (Pylypenko and Schlichting, 2004) . Loss of possible hydrogen bonds mediated by Thr residue in the membrane may indicate lower expression levels of all mutants due to structural instability (Fig. 3) .
In conclusion, we selected and analyzed mutant enzymes from CYP4A11 through directed evolution using a luminescent substrate. The enhanced enzymatic activity of CYP4A11 mutants for the luminescent substrate was not in accordance with lauric acid hydroxylation. Further investigation of CYP4A11 luminescent probe for application to directed evolution is required to warrant the correlation with its physiological substrate. Possibly, the fatty acid derived luminescent substrate with a comparative activity of lauric acid hydroxylation can be an alternative substrate for the high-throughput screening of CYP4A11 mutant library. WT -5.6 ± 0.6 CP2600 A24T/T263A 2.5 ± 0.4 CP2601 T263A 12.6 ± 1.9 CP2616 A24T/T263A/V430E 13.2 ± 2.9
